bf/NASDAQ:ACAD_icon.jpeg

COM:ACADIA

Acadia Pharmaceuticals

  • Stock

Last Close

16.18

22/11 18:59

Market Cap

2.83B

Beta: -

Volume Today

496.96K

Avg: -

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Pharmaceuticals
  • website

    acadia.com/
  • ipo date

    May 27, 2004

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, un...Show More

competitor of